Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Levetiracetam Teva

Levetiracetam Teva 250 mg film-coated tablets Levetiracetam Teva 500 mg film-coated tablets Levetiracetam Teva 750 mg film-coated tablets Levetiracetam Teva 1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10–11

HOS-214474 · Präparat HOS-155334

10  Frequency category MedDRA SOC Very Common Uncommon Rare Very rare common Gastrointestinal Abdominal Pancreatitis disorders pain, diarrhoea, dyspepsia, vomiting, nausea Hepatobiliary Liver function Hepatic failure, disorders test abnormal hepatitis Renal and Acute Kidney Urinary injury Disorders Skin and Rash Alopecia, Toxic epidermal subcutaneous eczema, necrolysis, tissue disorders pruritus, Stevens-Johnson syndrome, erythema multiforme Musculoskeleta Muscular Rhabdomyolysis l and weakness, and blood connective myalgia creatine tissue disorders phosphokinase increased(3) General Asthenia/ disorders and fatigue administration site conditions Injury, Injury poisoning and procedural complications (1) See Description of selected adverse reactions. (2) Very rare cases of development of obsessive-compulsive disorders (OCD) in patients with underlying history of OCD or psychiatric disorders have been observed in post-marketing surveillance. (3) Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.